First Wave BioPharma Inc FWBI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:31 PM EST
1.32UNCH (UNCH)
Volume
5,915
Close
1.32UNCH (UNCH)
Volume
117,388
52 week range
1.27 - 26.30
Loading...
  • Open1.32
  • Day High1.38
  • Day Low1.31
  • Prev Close1.32
  • 52 Week High26.30
  • 52 Week High Date01/22/21
  • 52 Week Low1.27
  • 52 Week Low Date12/06/21

Key Stats

  • Market Cap21.30M
  • Shares Out16.14M
  • 10 Day Average Volume0.22M
  • Dividend-
  • Dividend Yield-
  • Beta1.62
  • YTD % Change-8.65

KEY STATS

  • Open1.32
  • Day High1.38
  • Day Low1.31
  • Prev Close1.32
  • 52 Week High26.30
  • 52 Week High Date01/22/21
  • 52 Week Low1.27
  • 52 Week Low Date12/06/21
  • Market Cap21.30M
  • Shares Out16.14M
  • 10 Day Average Volume0.22M
  • Dividend-
  • Dividend Yield-
  • Beta1.62
  • YTD % Change-8.65

RATIOS/PROFITABILITY

  • EPS (TTM)-16.36
  • P/E (TTM)-0.08
  • Fwd P/E (NTM)-0.61
  • EBITDA (TTM)-64.729M
  • ROE (TTM)-2,580.20%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On First Wave BioPharma Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
First Wave BioPharma, Inc., formerly AzurRx BioPharma, Inc., is a clinical-stage biopharmaceutical company. It is engaged in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. It is focused on advancing a therapeutic development pipeline built around its two technologies: niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the...
James Sapirstein
Chairman of the Board, President, Chief Executive Officer
Daniel Schneiderman
Chief Financial Officer
Address
777 Yamato Road, Suite 502
Boca Raton, FL
33431
United States

Top Peers

SYMBOLLASTCHG%CHG
TRVI
Trevi Therapeutics Inc
0.70+0.014+2.0408%
PSTV
Plus Therapeutics Inc
0.9855+0.0155+1.60%
MTCR
Metacrine Inc
0.5563+0.033+6.31%
PALI
Palisade Bio Inc
1.19UNCHUNCH
ARTL
Artelo Biosciences Inc
0.4251-0.0098-2.2534%